Olympus Bolsters Respiratory Portfolio With Up To $340M Buy-Out Of Veran Medical Technologies
Olympus’ acquisition of Veran Medical Technologies will strengthen its respiratory portfolio.
You may also be interested in...
IV BioHoldings CEO Marty Keiser connects data, technology, capital and people to create start-ups focusing on liquid biopsy programs.
A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.
Caresyntax raised $130m in total funding to expand commercialization of its software that seeks to reduce variability and improve outcomes in the operating room.